haemosiderosis
Showing 1 - 21 of 21
Iron Status in BTM With Blood Transfusion
Not yet recruiting
- Beta-Thalassemia
- (no location specified)
Jul 13, 2021
Cardiac Surgery Trial in Amiens, Caen (SVO2 group / control group)
Completed
- Cardiac Surgery
- SVO2 group / control group
-
Amiens, France
- +1 more
May 28, 2020
Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)
Completed
- Alzheimer's Disease
- PF-04360365 0.1 mg/kg
- +5 more
-
Peoria, Arizona
- +41 more
Oct 11, 2022
Gall Bladder Status Among Chronic Haemolytic Anemia
Unknown status
- Gall Bladder Disease
- (no location specified)
Jul 29, 2018
MDS Trial in Worldwide (Azacitidine, Physician Choice)
Completed
- Myelodysplastic Syndromes
- Azacitidine
- Physician Choice
-
Birmingham, Alabama
- +107 more
Oct 16, 2019
Moderate to Severe Plaque-type Psoriasis Trial in Germany (Secukinumab)
Completed
- Moderate to Severe Plaque-type Psoriasis
-
Bad Bentheim, Germany
- +88 more
Apr 12, 2019
Complicated Skin and Soft Tissue Infection Trial in Worldwide (Ceftaroline fosamil, Vancomycin, Aztreonam)
Completed
- Complicated Skin and Soft Tissue Infection
- Ceftaroline fosamil
- +2 more
-
Chula Vista, California
- +90 more
Sep 1, 2017
Coronary Disease, Ventricular Dysfunction, Left Trial in London (Ivabradine, Placebo)
Completed
- Coronary Disease
- Ventricular Dysfunction, Left
- Ivabradine
- Placebo
-
London, United KingdomRoyal Brompton National Heart and Lung Hospital
Mar 13, 2018
Atherosclerosis, Ischemia, Myocardial Infarction Trial (Vorapaxar, Placebo)
HCMV Reactivation or HCMV End-Organ Disease Trial in Germany, United States (60 mg AIC246, 120 mg AIC246, 240 mg AIC246)
Completed
- HCMV Reactivation or HCMV End-Organ Disease
- 60 mg AIC246
- +3 more
-
Los Angeles, California
- +23 more
Jan 15, 2018
Speckle Tracking in the Evaluation of Sickle Cell Disease
Completed
- Sickle Cell Disease
- Cardiac echography
- +2 more
-
Brussels, BelgiumCHU Brugmann
Jul 25, 2016
MDS Trial in France (Epoetin beta (NeoRecormon))
Completed
- Myelodysplastic Syndromes
- Epoetin beta (NeoRecormon)
-
Le Kremlin-Bicêtre, Ile de France, France
- +30 more
Apr 28, 2015
Leukemia, Myelocytic, Acute MDS, MDS Trial (vorinostat, decitabine)
Completed
- Leukemia, Myelocytic, Acute Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- (no location specified)
Sep 4, 2015
Atrial Fibrillation, Vascular Risk Trial in Worldwide (clopidogrel (SR25990C), )
Completed
- Atrial Fibrillation
- Vascular Risk
- clopidogrel (SR25990C)
- placebo
-
Bridgewater, New Jersey
- +29 more
May 20, 2015
Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,
Completed
- Transfusional Iron Overload
- Transfusional Hemosiderosis
- Core Study: Deferasirox
- +5 more
-
Toronto, Ontario, Canada
- +20 more
Aug 13, 2014
Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS) Trial in Tampa (Lenalidomide, Recombinant human erythropoietin)
Completed
- Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
- Lenalidomide
- Recombinant human erythropoietin
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 31, 2013
Sickle Cell Disease, Iron Overload, Hemolytic Anemia Trial in Canada, United States (Deferasirox (ICL670), Deferoxamine (DFO))
Completed
- Sickle Cell Disease
- +2 more
- Deferasirox (ICL670)
- Deferoxamine (DFO)
-
Birmingham, Alabama
- +58 more
May 23, 2011
Atrial Fibrillation, Cardiovascular Disease Trial in Worldwide (Irbesartan, )
Completed
- Atrial Fibrillation
- Cardiovascular Disease
- Irbesartan
- placebo
-
Bridgewater, New Jersey
- +29 more
Sep 29, 2010